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ABSTRACT 
 
Hyperglycemia in type 2 diabetes results in excessive production of superoxide in mitochondria damage, poly ADP 
ribose polymerase activity and inhibition of glyceraldehide-3 Phosphate Dehidrogenase. These give raise to 
complicated reaction in the form of polyol pathway. Protein Kinase C (PKC) activation, increasing hexosamine 
Advanced Glycation End Products (AGES). Expression of several molecules intracellular Adhesive Moleculs-1 
leads to endothelial dysfunction. This study aims analyzing several atherogenic factors arising from the increase of 
blood glucose level in people with diabetes mellitus of type 2. Observational research with comparative sectional 
study in patient with diabtes mellitus of type 2 aged 30 – 60 years has been conducted. Sample of the research were 
conducted at 70 participants. Examination of PARP and ICAM-1 were conducted by Linked Immunosorbent Assay 
(ELISA) technique. Data were analyzed statistically by using t-test and chi-square. The mean of PARP activity in the 
type 2 DM group was 457 ± 81.34 Unit/µl, in non DM group it was 214 ± 75.54 Unit/µl. Mean of ICAM-1 
concentration in DM group of type 2 was 670,.93 ± 192.44 ng/ml and in non DM group it was 360.01 ± 137.56 
ng/ml. concentration in DM group of type 2. There was a significant correlation between the increasing of PARP 
activity and the increasing of ICAM-1 concentration. In addition, there was also a significant correlation between 
PARP activity. ICAM-1 is atherogenic factors. 
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INTRODUCTION 
 
Type 2 DM is a degenerative illness that has become a significant concern in Indonesia and the rest of the world. 
The number of cases of type 2 DM are expected to increase very year. A patient who has type 2 DM shows 
abnormality in both insulin secretion and its effect [1,2]. There are 3 main reasons for the increasing number of  type 
2 DM patients, improved prosperity change to peoples, and reduced physical activity  type 2 DMis characterized by 
un controlled hyperglycemia (glucotoxicity) with  HbA1c levels > 7 % and 2 hours postprandial blood glucose ≥ 
200 mg/dl. The uncontrolled level of blood glucose damage the beta cells this causing a decline in insulin secretion 
[3,4,5],. Without treatment, the patient will suffer chronic complications, including microvascular, macrovascular 
and tissue damage. Insulin resistance and beta cell dysfunction are the main cause of hyperglycemia in DM type 2. 
High intracellular glucose and excessive mitochondrial superoxide production cause DNA damage. Damaged DNA 
activities poly ADP ribose polymerase (PARP) which in turn inhibits glyceraldehide-3phospate dehidrogenase 
(GAPDH). GAPDH is essential for intracellular glycolysis. As a consequence complications in DM type 2 including 
effects on the polyol pathway, PKC activation through DAG, and the formation of advanced glycosylation End 
products (AGEs) [6,7,8]. Those reactions will increase the formation of ROS consequently expression of molecular 
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that cause damage to tissue increase [9,10]. Expression of Intrtraceluller Adhesive Moleculers-1 (ICAM-1), 
inactivates NO. In the end it induced endothelial dysfunction [11,12]. 
 
These changes affect the polyol pathway, activate protein kinase C, increase flux through the hexosamine pathway 
and formation of advanced glycation end product, expression of intracellular adhesive molecule -1 and nitrit oxide. 
The end result is endhothelial dysfunction [13,14,15]. The aim of this study was to observe several antherogenic 
factors that are affected by the increased blood glucose levels in diabetes mellitus type 2 patients. Atherogenic 
factors is ICAM-1 concentration. 
 
EXPERIMENTAL SECTION 
 
Observational research was conducted using a cross sectional study comparative on patients with type 2 DM aged 30 
– 60 years old, 19 males and 16 females. The study group comprised 35 patients with  type 2 DM who 
haspostprandial bloodglucose ≥ 200 mg/dl, and HbA1c level ≥ 7%, either the patients on hospitalized at the 
polyclinics Internal medicine RSUP. M Djamil Padang. The control group was 35 non-DM volunteers.  
 
Sample was taken with random block on patients type 2 DM who were hospitalized in general medicine Dr. M. 
Djamil hospital, Padang. Type 2 DM patients consist of 19 males and 16 females. Each patient is undergoing 
conducting anamnesis involving interview, smoking habit, gender, blood glucose checkup, weight, height, hip and 
wise circumference. Hereafter, blood glucose and HbA1c checkup were conducted. People without DM function as 
a comparator who got the same treatment as the patients with blood glucose level post prandial ≤ 200 mg/dl and 
HbA1c ≤ 7%. Each sample and comparator underwent vena blood taken procedure for 10 ml to measure the HbA1c 
level with variant hemoglobin testing system technique. In order to check up blood glucose checkup, PARP, ICAM-
1  were given the form of serum. 
 
The blood glucose of each patient was examined using an enzyme method and HbA1c level with variant hemoglobin 
testing system technique. PARP activation, ICAM-1 and NO level are checked with Enzyme Linked Imunosorbent 
Assay (ELISA) technique. Statistical analysis used t-test and chi-square.  
 
RESULTS AND DISCUSSION 
 
Table 1. The Characteristic of Research’s Subject 
 
Characteristic of research’s subject type 2 DM Mean ± SD 
Non DM 
Mean ± SD p 
Age (years) 51,66  ± 5,06 49,77 ± 5,27 0,13 
Body Mass Index, BMT (kg/m2) 25,00  ±  2,31 24,21 ± 2,69 0,19 
Blood glucose fast (mg/dl) 191,60  ± 35,47 93,37 ± 7,18 < 0,001 
Blood glucose 2 hours  PP (mg/dl) 367,77 ± 70,68 125,06 ± 16,01 < 0,001 
HbA1c(%) 11,19  ± 2,04 6,02 ± 0,56 < 0,001 
 
Table 2. The Average of PARP Activities on Patient with DM of type 2 and Non DM 
 
Group n PARP activity (Unit/µl) Mean ± SD p 
Type 2 DM 35 457  ±  81,34 0,01 Non DM 35 214  ±  75,54 
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Figure 1. Correlation HbA1c with PARP activity 
Table 3. The Average of ICAM-1 Level on Patients with Type 2 DM and Non DM 
 
Group n Cocentration ICAM-1 (ng/ml) Mean ± SD p 
Type 2 DM 35 670,93 ± 192,44 
< 0,001 Non DM 35 360, 01 ± 37,56 
 
There was a significant difference in NO level between patients with DM type 2 and the control non DM group (p ≤ 
0,001). A significant correlation between the increasing in PARP activity and ICAM_1 level were shown in figure 2 
and 3 respectively. 
 
The advanced of PARP level due to the increasing of Intracellular glucose levels that causes superoxide on 
mitochondria increase (Reusch, 2003., Brownlee, 2005). This condition leads to the destruction of DNA 
mitochondria and DNA nucleus [12,13]. PARP is a marker of DNA damage by catalyzing the poly-ADP-
ribosylation on several core proteins as histon. The result of other researches (Reusch, 2003., Monnier et al, 2006) 
show that the increase of  ICAM-1 level on patients with DM of type 2 DM occured due to the vascular destruction 
as a result of excessive superoxide. The excessive superoxide in mitochondria damages the DNA, which in turn 
activates the PARP. The activation of PARP inhibits GAPDH that lead to PKC activation. The increase of PKC 
activity increases the ICAM-1 level. Glucose level in blood and in related to the damage to the corpus system as a 
result of repeatedly elevated glucose leads that follow food consumption. 
  
From the result of the research, it is concluded that there were average increase of PARP activities and ICAM-1 
level, on patients with DM of type 2 compared to the control of non DM. There is a significant correlation between 
the increasing of PARP activities with ICAM-1 level. 
 
The result of the research could be used as guidance in conducting the treatment to patient with DM of type 2. PARP 
inhibitor or GAPDH activator could be developed as a treatment so that DNA damage in patients with DM type 2 
doesn’t inhibit the glycolysis pathway not cause atherogenesis factor. 
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Figure 2. Correlation between HbA1c with ICAM-1 concentration 
 
Figure 3. Correlation between PARP activity with ICAM-1 concentration 
 
CONCLUSION 
 
Increasing blood glucose caused increasing PARP activity, where atherogenic factor was ICAM-1 concentration. 
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